Editorial Board About Us

Hemostasis

All articles from this key word are listed below.

Volume 5, Number 1 Review Articles

Laparoscopic Total and Partial Nephrectomy-- The New Standard?

Technique Update

Laparoscopic radical nephrectomy has been shown in long-term follow-up to provide shorter patient hospitalization and effective cancer control with no significant difference in survival compared with open radical nephrectomy. The major technical issue for success of laparoscopic partial nephrectomy is hemostatic control, and several techniques have been developed to improve control. Laparoscopic partial nephrectomy continues to evolve along two therapeutic technical avenues: hilar clamping with ischemia versus no hilar clamping. The benefits of laparoscopy for the kidney have clearly been demonstrated in terms of less pain, decreased convalescence, and decreased narcotic requirements. With short-term outcomes demonstrating laparoscopic partial nephrectomy as an efficacious procedure, the role of laparoscopic partial nephrectomy should continue to increase. [Rev Urol. 2003;5(1):9–14]

Hemostasis Laparoscopic radical nephrectomy Renal neoplasms Partial nephrectomy Radiofrequency ablation

Volume 7, Number 2 Meeting Reviews

Endourology: A Basic Science and Clinical Update

Laparoscopy Metabolic evaluation Hemostasis Shock wave lithotripsy Endourology Tissue sealants Ureteral obstruction Training

Volume 8, Number 3 Review Articles

New Generation Tissue Sealants and Hemostatic Agents: Innovative Urologic Applications

Treatment Update

Michael A Traver Dean G Assimos

Control of blood loss during urologic surgery is paramount to the success of patient recovery. Hemostatic agents and tissue sealants are used routinely to prevent excess blood loss and in reconstruction during surgical repair. Some of the available products include thrombin sealant, fibrin glue, bovine serum/ albumin/glutaraldehyde, and gelatin matrix. Each of these agents differs in mechanism, cost, and application. Complications can include allergic reactions or thromboembolism and the risk of contracting bovine spongiform encephalitis or hepatitis. Many new hemostatic agents are being developed and approved. The benefits and risks of use of these agents versus conventional treatment need to be considered on a case-by-case basis by the surgeon. [Rev Urol. 2006;8(3):104-111]

Hemostasis Thrombin sealants Fibrin glue Gelatin matrix Thrombin

Volume 17, Number 3 Review Articles

Current Status of Hemostatic Agents and Sealants in Urologic Surgical Practice

Management Update

Sashi S Kommu Christopher G Eden Raj A Persad Neil J Barber Christopher J Anderson Utsav D Reddy Amr M Emara Robert McArthur

There has been a recent and near exponential increase in the use of hemostatic agents and sealants to supplement the rapidly evolving methods in the surgical management of urologic patients. This article reviews the use of hemostatic agents and sealants in current urologic practice. [Rev Urol. 2015;17(3):150-159 doi: 10.3909/riu0673] © 2015 MedReviews®, LLC

Hemostasis Tissue adhesion Urologic surgery

Volume 17, Number 1 Original Research

Hemostasis During Urologic Surgery: Fibrin Sealant Compared With Absorbable Hemostat

David M. Albala Jonathan Batiller Liza Ovington Jessica Shen John Albanese Bogdan Ilie Richard Kocharian Jerome B Riebman

In the United States, fibrin sealants have been used to achieve hemostasis for nearly two decades. Although their clinical utility was first demonstrated in cardiac surgery, their effectiveness and safety have since been demonstrated to extend to a wide array of procedures. Fibrin sealants typically contain two components—fibrinogen and thrombin—that are combined and delivered simultaneously to a target bleeding site in order to achieve hemostasis. However, many commercial formulations contain other additional components, such as antifibrinolytic agents, that have been associated with adverse outcomes. This subanalysis compares the safety and effectiveness of a fibrin sealant versus an absorbable hemostat for achieving hemostasis during urologic procedures with mild to moderate bleeding. [Rev Urol. 2015;17(1):25-30 doi: 10.3909/ricm0647] © 2015 MedReviews®, LLC

Bleeding Hemostasis Hemostatics Fibrin tissue adhesive Urologic surgical procedures Surgical technique